These findings provide novel mechanistic insights into the role of MORC2 in promoting colorectal cancer metastasis and highlight the MORC2/RBM39/CDK5RAP2 axis as a potential therapeutic target for colorectal cancer. Here, RBM39 is linked to colorectal cancer.